Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
October 19, 2022
DJS Antibodies to be acquired by AbbVie
August 3, 2022
MiroBio to be acquired by Gilead Sciences for approximately $405 million
July 17, 2022
Oxford Science Enterprises raises £250 million
Article links to firstlightfusion.com
April 4, 2022
First Light Fusion achieves world first fusion result, proving unique new target technology
Article links to www.omass.com
April 27, 2022
OMass Therapeutics raises $100 million in Series B financing to progress drug pipeline in immunology and rare diseases
Article links to www.oslerdiagnostics.com
November 7, 2022
Osler Diagnostics raises $85 million in Series C financing
Article links to quantummotion.tech
October 25, 2022
Quantum Motion industry milestone brings mass production of quantum chips closer
December 13, 2022
OxfordVR to combine with BehaVR to confront the mental health crisis with the largest VR delivery platform for evidence-based digital therapeutics
All News
28•03•23
Portfolio News
Grey Wolf Therapeutics
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours
26•01•23
Portfolio News
Grey Wolf Therapeutics
Grey Wolf Therapeutics closes oversubscribed $49 million Series B financing to advance first-of-its-kind neoantigen creation approaches
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal